Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
Treatment of cognitive impairment in patients with multiple sclerosis.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Immunotherapy of Neuromyelitis Optica.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
MicroRNA-21 with therapeutic potential in autoimmune diseases.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.
Environmental factors and multiple sclerosis severity: a descriptive study.
Synthesis of genistein coupled with sugar derivatives and their inhibitory effect on nitric oxide production in macrophages.
Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Pages
« first
‹ previous
…
345
346
347
348
349
350
351
352
353
…
next ›
last »